Table of Contents 1 RESEARCH SCOPE 1.1 Research Product Definition 1.2 Research Segmentation 1.2.1 Product Type 1.2.2 Main product Type of Major Players 1.3 Demand Overview 1.4 Research Methodology 2 GLOBAL ADDISON’S DISEASE THERAPEUTICS INDUSTRY 2.1 Summary about Addison’s Disease Therapeutics Industry 2.2 Addison’s Disease Therapeutics Market Trends 2.2.1 Addison’s Disease Therapeutics Production & Consumption Trends 2.2.2 Addison’s Disease Therapeutics Demand Structure Trends 2.3 Addison’s Disease Therapeutics Cost & Price 3 MARKET DYNAMICS 3.1 Manufacturing & Purchasing Behavior in 2020 3.2 Market Development under the Impact of COVID-19 3.2.1 Drivers 3.2.2 Restraints 3.2.3 Opportunity 3.2.4 Risk 4 GLOBAL MARKET SEGMENTATION 4.1 Region Segmentation (2017 to 2021f) 4.1.1 North America (U.S., Canada and Mexico) 4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe) 4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific) 4.1.4 South America (Brazil,, Argentina, Rest of Latin America) 4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa) 4.2 Product Type Segmentation (2017 to 2021f) 4.2.1 Medication 4.2.2 Hormonal Therapy 4.2.3 Surgery 4.3 Consumption Segmentation (2017 to 2021f) 4.3.1 Hospitals 4.3.2 Homecare 4.3.3 Specialty Clinics 4.3.4 Others 5 NORTH AMERICA MARKET SEGMENT 5.1 Region Segmentation (2017 to 2021f) 5.1.1 U.S. 5.1.2 Canada 5.1.3 Mexico 5.2 Product Type Segmentation (2017 to 2021f) 5.2.1 Medication 5.2.2 Hormonal Therapy 5.2.3 Surgery 5.3 Consumption Segmentation (2017 to 2021f) 5.3.1 Hospitals 5.3.2 Homecare 5.3.3 Specialty Clinics 5.3.4 Others 5.4 Impact of COVID-19 in North America 6 EUROPE MARKET SEGMENTATION 6.1 Region Segmentation (2017 to 2021f) 6.1.1 Germany 6.1.2 UK 6.1.3 France 6.1.4 Italy 6.1.5 Rest of Europe 6.2 Product Type Segmentation (2017 to 2021f) 6.2.1 Medication 6.2.2 Hormonal Therapy 6.2.3 Surgery 6.3 Consumption Segmentation (2017 to 2021f) 6.3.1 Hospitals 6.3.2 Homecare 6.3.3 Specialty Clinics 6.3.4 Others 6.4 Impact of COVID-19 in Europe 7 ASIA-PACIFIC MARKET SEGMENTATION 7.1 Region Segmentation (2017 to 2021f) 7.1.1 China 7.1.2 India 7.1.3 Japan 7.1.4 South Korea 7.1.5 Southeast Asia 7.1.6 Australia 7.1.7 Rest of Asia Pacific 7.2 Product Type Segmentation (2017 to 2021f) 7.2.1 Medication 7.2.2 Hormonal Therapy 7.2.3 Surgery 7.3 Consumption Segmentation (2017 to 2021f) 7.3.1 Hospitals 7.3.2 Homecare 7.3.3 Specialty Clinics 7.3.4 Others 7.4 Impact of COVID-19 in Europe 8 SOUTH AMERICA MARKET SEGMENTATION 8.1 Region Segmentation (2017 to 2021f) 8.1.1 Brazil 8.1.2 Argentina 8.1.3 Rest of Latin America 8.2 Product Type Segmentation (2017 to 2021f) 8.2.1 Medication 8.2.2 Hormonal Therapy 8.2.3 Surgery 8.3 Consumption Segmentation (2017 to 2021f) 8.3.1 Hospitals 8.3.2 Homecare 8.3.3 Specialty Clinics 8.3.4 Others 8.4 Impact of COVID-19 in Europe 9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION 9.1 Region Segmentation (2017 to 2021f) 9.1.1 GCC 9.1.2 North Africa 9.1.3 South Africa 9.1.4 Rest of Middle East and Africa 9.2 Product Type Segmentation (2017 to 2021f) 9.2.1 Medication 9.2.2 Hormonal Therapy 9.2.3 Surgery 9.3 Consumption Segmentation (2017 to 2021f) 9.3.1 Hospitals 9.3.2 Homecare 9.3.3 Specialty Clinics 9.3.4 Others 9.4 Impact of COVID-19 in Europe 10 COMPETITION OF MAJOR PLAYERS 10.1 Brief Introduction of Major Players 10.1.1 Bristol-Myers Squibb 10.1.2 Merck 10.1.3 Novartis 10.1.4 Pfizer 10.1.5 Takeda Pharmaceutical 10.1.6 Bio-Techne 10.1.7 GlaxoSmithKline 10.1.8 Lupin Pharmaceuticals 10.1.9 Abbott 10.1.10 Amgen 10.1.11 Bayer 10.1.12 Biogen 10.1.13 Eli Lilly and Company 10.1.14 Boehringer Ingelheim International 10.1.15 Diurnal 10.1.16 Switzer Life Science 10.1.17 Recipharm 10.2 Addison’s Disease Therapeutics Sales Date of Major Players (2017-2020e) 10.2.1 Bristol-Myers Squibb 10.2.2 Merck 10.2.3 Novartis 10.2.4 Pfizer 10.2.5 Takeda Pharmaceutical 10.2.6 Bio-Techne 10.2.7 GlaxoSmithKline 10.2.8 Lupin Pharmaceuticals 10.2.9 Abbott 10.2.10 Amgen 10.2.11 Bayer 10.2.12 Biogen 10.2.13 Eli Lilly and Company 10.2.14 Boehringer Ingelheim International 10.2.15 Diurnal 10.2.16 Switzer Life Science 10.2.17 Recipharm 10.3 Market Distribution of Major Players 10.4 Global Competition Segmentation 11 MARKET FORECAST 11.1 Forecast by Region 11.2 Forecast by Demand 11.3 Environment Forecast 11.3.1 Impact of COVID-19 11.3.2 Geopolitics Overview 11.3.3 Economic Overview of Major Countries 12 REPORT SUMMARY STATEMENT

List of Table 1.Table Addison’s Disease Therapeutics Product Type Overview 2.Table Addison’s Disease Therapeutics Product Type Market Share List 3.Table Addison’s Disease Therapeutics Product Type of Major Players 4.Table Brief Introduction of Bristol-Myers Squibb 5.Table Brief Introduction of Merck 6.Table Brief Introduction of Novartis 7.Table Brief Introduction of Pfizer 8.Table Brief Introduction of Takeda Pharmaceutical 9.Table Brief Introduction of Bio-Techne 10.Table Brief Introduction of GlaxoSmithKline 11.Table Brief Introduction of Lupin Pharmaceuticals 12.Table Brief Introduction of Abbott 13.Table Brief Introduction of Amgen 14.Table Brief Introduction of Bayer 15.Table Brief Introduction of Biogen 16.Table Brief Introduction of Eli Lilly and Company 17.Table Brief Introduction of Boehringer Ingelheim International 18.Table Brief Introduction of Diurnal 19.Table Brief Introduction of Switzer Life Science 20.Table Brief Introduction of Recipharm 21.Table Products & Services of Bristol-Myers Squibb 22.Table Products & Services of Merck 23.Table Products & Services of Novartis 24.Table Products & Services of Pfizer 25.Table Products & Services of Takeda Pharmaceutical 26.Table Products & Services of Bio-Techne 27.Table Products & Services of GlaxoSmithKline 28.Table Products & Services of Lupin Pharmaceuticals 29.Table Products & Services of Abbott 30.Table Products & Services of Amgen 31.Table Products & Services of Bayer 32.Table Products & Services of Biogen 33.Table Products & Services of Eli Lilly and Company 34.Table Products & Services of Boehringer Ingelheim International 35.Table Products & Services of Diurnal 36.Table Products & Services of Switzer Life Science 37.Table Products & Services of Recipharm 38.Table Market Distribution of Major Players 39.Table Global Major Players Sales Revenue (Million USD) 2017-2020e 40.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e 41.Table Global Addison’s Disease Therapeutics Market Forecast (Million USD) by Region 2021f-2026f 42.Table Global Addison’s Disease Therapeutics Market Forecast (Million USD) Share by Region 2021f-2026f 43.Table Global Addison’s Disease Therapeutics Market Forecast (Million USD) by Demand 2021f-2026f 44.Table Global Addison’s Disease Therapeutics Market Forecast (Million USD) Share by Demand 2021f-2026f